Bioanalytical Systems, Inc. (BASI) financial statements (2020 and earlier)

Company profile

Business Address 2701 KENT AVE
WEST LAFAYETT, IN 47906-1382
State of Incorp. IN
Fiscal Year End September 30
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6067734343864389811,304
Cash and cash equivalents6067734343864389811,304
Receivables7,1784,1282,5301,6492,9042,5573,621
Inventory, net of allowances, customer advances and progress billings1,0951,1829131,4531,4661,5641,379
Inventory1,0951,1829131,4531,4661,5641,379
Prepaid expense1,200966814798773675238
Other undisclosed current assets2,3421,0126155911,110878691
Total current assets:12,4218,0615,3064,8776,6916,6557,233
Noncurrent Assets
Nontrade receivables1301158751  
Property, plant and equipment22,82816,61014,96516,13615,98915,94916,913
Intangible assets, net (including goodwill)6,4916,39038381,0091,0091,383
Goodwill3,6173,07238381,0091,0091,383
Intangible assets, net (excluding goodwill)2,8743,318     
Regulated entity, other noncurrent assets   109412221
Deferred income tax assets31
Other noncurrent assets79302127323947
Other undisclosed noncurrent assets 62     
Total noncurrent assets:29,55923,20715,11116,26217,12417,11918,364
TOTAL ASSETS:41,98031,26820,41721,13923,81523,77425,597
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,5614,7633,2744,0674,5984,5345,303
Accounts payable4,9413,1922,0522,9652,8582,6723,584
Accrued liabilities2,6201,5711,2021,0891,7101,8421,689
Taxes payable  2013302030
Deferred revenue6,726
Debt1,1099963523,7921,0161,0651,600
Derivative instruments and hedges, liabilities   35189676612
Restructuring reserve3491,1171,1171,117  
Customer advances and deposits2,9803,1143,4142,990
Other undisclosed current liabilities1,7364,925 1,358862023,511
Total current liabilities:17,48111,8017,72313,4839,3039,46711,026
Noncurrent Liabilities
Long-term debt and lease obligation13,7718,5834,2271983,7344,7505,112
Long-term debt, excluding current maturities13,7718,5464,158 3,6664,4524,641
Capital lease obligations376919868298471
Liabilities, other than long-term debt    5021 
Derivative instruments and hedges, liabilities    5021 
Other undisclosed noncurrent liabilities18      
Total noncurrent liabilities:13,7898,5834,2271983,7844,7715,112
Total liabilities:31,27020,38411,95013,68113,08714,23816,138
Stockholders' equity
Stockholders' equity attributable to parent10,71010,8848,4677,45810,7289,5369,459
Preferred stock35351,0351,1851,1851,1851,335
Common stock2,5892,5232,0231,9891,9881,9801,887
Additional paid in capital25,18324,55721,44621,24021,19321,15419,925
Accumulated other comprehensive income (loss)   (35)53732
Accumulated deficit(17,097)(16,231)(16,037)(16,921)(13,691)(14,790)(13,720)
Total stockholders' equity:10,71010,8848,4677,45810,7289,5369,459
TOTAL LIABILITIES AND EQUITY:41,98031,26820,41721,13923,81523,77425,597

Income statement (P&L) ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Revenues43,61626,34624,24220,44122,69824,58422,068
Revenue, net24,24220,44122,69824,58422,068
Cost of revenue
(Cost of Goods and Services Sold)
(30,695)(18,230)(16,545)(16,016)(15,209)(16,622)(15,013)
Gross profit:12,9218,1167,6974,4257,4897,9627,055
Operating expenses(13,074)(8,102)(6,419)(7,465)(6,580)(7,628)(6,225)
Operating income (loss):(153)141,278(3,040)909334830
Nonoperating income965632797
Gain on contract termination    322  
Other nonoperating income9656597
Interest and debt expense(642)(274)(375)(399)(287)(536)(649)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   189165(870)601
Income (loss) from continuing operations before income taxes:(786)(254)908(3,244)1,114(1,063)789
Income tax expense (benefit)(4)60(24)14(15)(7)(16)
Income (loss) before gain (loss) on sale of properties:(790)(194)884(3,230)1,099(1,070)773
Other undisclosed net loss (297)     
Net income (loss):(790)(491)884(3,230)1,099(1,070)773
Other undisclosed net income attributable to parent 297     
Net income (loss) available to common stockholders, basic:(790)(194)884(3,230)1,099(1,070)773
Dilutive securities, effect on basic earnings per share    (487)  
Net income (loss) available to common stockholders, diluted:(790)(194)884(3,230)612(1,070)773

Comprehensive Income ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Net income (loss):(790)(491)884(3,230)1,099(1,070)773
Comprehensive income (loss):(790)(491)884(3,230)1,099(1,070)773
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 29735(88)46(25)3
Comprehensive income (loss), net of tax, attributable to parent:(790)(194)919(3,318)1,145(1,095)776

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: